Vorsetuzumab mafodotin (SGN-75) is an auristatin-based, CD70-targeted antibody-drug conjugate (ADC), composed of the humanized monoclonal antibody Vorsetuzumab and the ADC cytotoxic molecule MMAF, and exerts antitumor effects.
CAS Number:
[1165741-01-4]
Target:
Antibody-Drug Conjugates (ADCs)|||Immunology/Inflammation related
T9901A-221
* VAT and and shipping costs not included. Errors and price changes excepted